S Antoniak1, K Tatsumi1, Y Hisada1, J J Milner2, S D Neidich2, C M Shaver3, R Pawlinski1, M A Beck2, J A Bastarache3, N Mackman1. 1. Department of Medicine, Division of Hematology and Oncology, UNC McAllister Heart Institute, Chapel Hill, NC, USA. 2. Department of Nutrition, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 3. Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Abstract
UNLABELLED: Essentials H1N1 Influenza A virus (IAV) infection is a hemostatic challenge for the lung. Tissue factor (TF) on lung epithelial cells maintains lung hemostasis after IAV infection. Reduced TF-dependent activation of coagulation leads to alveolar hemorrhage. Anticoagulation might increase the risk for hemorrhages into the lung during severe IAV infection. SUMMARY: Background Influenza A virus (IAV) infection is a common respiratory tract infection that causes considerable morbidity and mortality worldwide. Objective To investigate the effect of genetic deficiency of tissue factor (TF) in a mouse model of IAV infection. Methods Wild-type mice, low-TF (LTF) mice and mice with the TF gene deleted in different cell types were infected with a mouse-adapted A/Puerto Rico/8/34 H1N1 strain of IAV. TF expression was measured in the lungs, and bronchoalveolar lavage fluid (BALF) was collected to measure extracellular vesicle TF, activation of coagulation, alveolar hemorrhage, and inflammation. Results IAV infection of wild-type mice increased lung TF expression, activation of coagulation and inflammation in BALF, but also led to alveolar hemorrhage. LTF mice and mice with selective deficiency of TF in lung epithelial cells had low basal levels of TF and failed to increase TF expression after infection; these two strains of mice had more alveolar hemorrhage and death than controls. In contrast, deletion of TF in either myeloid cells or endothelial cells and hematopoietic cells did not increase alveolar hemorrhage or death after IAV infection. These results indicate that TF expression in the lung, particularly in epithelial cells, is required to maintain alveolar hemostasis after IAV infection. Conclusion Our study indicates that TF-dependent activation of coagulation is required to limit alveolar hemorrhage and death after IAV infection.
UNLABELLED: Essentials H1N1InfluenzaA virus (IAV) infection is a hemostatic challenge for the lung. Tissue factor (TF) on lung epithelial cells maintains lung hemostasis after IAV infection. Reduced TF-dependent activation of coagulation leads to alveolar hemorrhage. Anticoagulation might increase the risk for hemorrhages into the lung during severe IAV infection. SUMMARY: Background InfluenzaA virus (IAV) infection is a common respiratory tract infection that causes considerable morbidity and mortality worldwide. Objective To investigate the effect of genetic deficiency of tissue factor (TF) in a mouse model of IAV infection. Methods Wild-type mice, low-TF (LTF) mice and mice with the TF gene deleted in different cell types were infected with a mouse-adapted A/Puerto Rico/8/34 H1N1 strain of IAV. TF expression was measured in the lungs, and bronchoalveolar lavage fluid (BALF) was collected to measure extracellular vesicle TF, activation of coagulation, alveolar hemorrhage, and inflammation. Results IAV infection of wild-type mice increased lung TF expression, activation of coagulation and inflammation in BALF, but also led to alveolar hemorrhage. LTF mice and mice with selective deficiency of TF in lung epithelial cells had low basal levels of TF and failed to increase TF expression after infection; these two strains of mice had more alveolar hemorrhage and death than controls. In contrast, deletion of TF in either myeloid cells or endothelial cells and hematopoietic cells did not increase alveolar hemorrhage or death after IAV infection. These results indicate that TF expression in the lung, particularly in epithelial cells, is required to maintain alveolar hemostasis after IAV infection. Conclusion Our study indicates that TF-dependent activation of coagulation is required to limit alveolar hemorrhage and death after IAV infection.
Authors: S Idell; K K James; E G Levin; B S Schwartz; N Manchanda; R J Maunder; T R Martin; J McLarty; D S Fair Journal: J Clin Invest Date: 1989-08 Impact factor: 14.808
Authors: A Phillip Owens; Freda H Passam; Silvio Antoniak; Stephanie M Marshall; Allison L McDaniel; Lawrence Rudel; Julie C Williams; Brian K Hubbard; Julie-Ann Dutton; Jianguo Wang; Peter S Tobias; Linda K Curtiss; Alan Daugherty; Daniel Kirchhofer; James P Luyendyk; Patrick M Moriarty; Shanmugam Nagarajan; Barbara C Furie; Bruce Furie; Douglas G Johns; Ryan E Temel; Nigel Mackman Journal: J Clin Invest Date: 2012-01-03 Impact factor: 14.808
Authors: Martha Sue Carraway; Karen E Welty-Wolf; Debra L Miller; Thomas L Ortel; Steven Idell; Andrew J Ghio; Lars C Petersen; Claude A Piantadosi Journal: Am J Respir Crit Care Med Date: 2003-05-01 Impact factor: 21.405
Authors: Thomas W Geisbert; Lisa E Hensley; Peter B Jahrling; Tom Larsen; Joan B Geisbert; Jason Paragas; Howard A Young; Terry M Fredeking; William E Rote; George P Vlasuk Journal: Lancet Date: 2003-12-13 Impact factor: 79.321
Authors: R Pawlinski; M Tencati; T Holscher; B Pedersen; T Voet; R E Tilley; P Marynen; N Mackman Journal: J Thromb Haemost Date: 2007-08 Impact factor: 5.824
Authors: William Bain; Tolani Olonisakin; Minting Yu; Yanyan Qu; Mei Hulver; Zeyu Xiong; Huihua Li; Joseph Pilewski; Rama K Mallampalli; Mehdi Nouraie; Anuradha Ray; Prabir Ray; Zhenyu Cheng; Robert M Q Shanks; Claudette St Croix; Roy L Silverstein; Janet S Lee Journal: Blood Adv Date: 2019-02-12
Authors: Susanna H M Sluka; Simon F Stämpfli; Alexander Akhmedov; Tanja Klein-Rodewald; Adrián Sanz-Moreno; Marion Horsch; Paula Grest; Andrea S Rothmeier; Birgit Rathkolb; Anja Schrewe; Johannes Beckers; Frauke Neff; Eckhard Wolf; Giovanni G Camici; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Thomas F Lüscher; Wolfram Ruf; Felix C Tanner Journal: Haematologica Date: 2019-09-05 Impact factor: 9.941
Authors: J B Kral-Pointner; W C Schrottmaier; V Horvath; H Datler; L Hell; C Ay; B Niederreiter; B Jilma; J A Schmid; A Assinger; N Mackman; S Knapp; G Schabbauer Journal: J Thromb Haemost Date: 2017-06-20 Impact factor: 5.824